Shop Apotheke Europe's operating cash flow stood at EUR -10.9 mil in 2Q2022, down 85.5% when compared to the previous year. Historically, between 4Q2013 - 2Q2022, the firm’s operating cash flow reached a high of EUR 28.2 mil in 1Q2021 and a low of EUR -33.0 mil in 4Q2019.
Shop Apotheke Europe's total investments stood at EUR -18.3 mil and accounted for 4.48% of sales in 2Q2022. This is compared to an average of 3.66% as seen over the last five years.
Cash from financing amounted to EUR -1.67 mil, so the company generated EUR -30.8 mil net cash in 2Q2022.
At the end of 2Q2022, the company had a net debt of EUR 4.60 mil, or -0.073x of EBITDA and 1.22% of equity. Net working capital amounted to EUR 52.3 mil, or 18.2% of sales. Cash conversion cycle is negative and reached 16.7 days days in 2Q2022. This means Shop Apotheke Europe generates revenue from customers before it has to pay its suppliers for inventory, among other things.
You can see all the company’s data at Shop Apotheke Europe profile, or you can download a report on the company in the report section.
Helgi Library 
